Trials / Active Not Recruiting
Active Not RecruitingNCT07252258
Comparison of Frequency of Calcium Hydroxide Mixed With 0.2% Chlorhexidine Versus Saline as Intracanal Medicament in Periapical Periodontitis-A Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Aqsa Afzal · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled trial aims to compare the effectiveness of calcium hydroxide mixed with 0.2% chlorhexidine digluconate versus calcium hydroxide mixed with saline as intracanal medicaments in reducing postoperative pain in patients with apical periodontitis. A total of 80 adult patients with anterior teeth diagnosed with apical periodontitis will be randomly assigned to two equal groups. After standard chemomechanical root canal preparation, Group A will receive calcium hydroxide with saline, while Group B will receive calcium hydroxide with 0.2% chlorhexidine. Postoperative pain will be assessed using a 10-point Visual Analogue Scale (VAS) at 12, 24, and 48 hours. The primary outcome is the frequency and severity of pain at 24 hours. Data will be analyzed using chi-square or Fisher's exact test, with a significance level of p \< 0.05. The study aims to determine whether the addition of chlorhexidine improves the analgesic and antimicrobial effectiveness of calcium hydroxide during root canal treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcium Hydroxide + Normal Saline | Calcium hydroxide powder mixed with sterile normal saline and placed inside the root canal as intracanal medicament. |
| DRUG | Calcium Hydroxide + 0.2% Chlorhexidine Digluconate | Calcium hydroxide powder combined with 0.2% chlorhexidine solution and placed inside the root canal as intracanal medicament. |
Timeline
- Start date
- 2025-07-15
- Primary completion
- 2026-02-01
- Completion
- 2026-02-15
- First posted
- 2025-11-26
- Last updated
- 2025-11-26
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07252258. Inclusion in this directory is not an endorsement.